Reports on October 2, 2026, detailed insider buying at Lipocine Inc. Director John W. Higuchi acquired 25,007 shares through open-market purchases. These transactions occurred on September 29 and September 30. His total direct ownership in the company now stands at 241,365 shares.
Analysts often interpret insider buying as a bullish signal, suggesting management confidence in future prospects and current valuation. Disclosures indicate Higuchi has consistently purchased Lipocine stock over the past year. He has not sold any shares during this period, reinforcing this sentiment.